SCHEMBL4806571

SCHEMBL4806571

C#CC(O)(c1ccccc1)c1ccc(N(C)C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.52
ALDH1A1 P00352 6/20 0.42
RAB9A P51151 3/20 0.42
HPGD P15428 2/20 0.42
NPC1 O15118 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TSHR P16473 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPK1 P28482 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
RELA Q04206 1/20 0.40
GFER P55789 1/20 0.40
ALOX15 P16050 1/20 0.39
NPY2R P49146 1/20 0.37
MAPT P10636 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NR1H2 P55055 2/20 0.37
NR1H3 Q13133 1/20 0.36
KCNK3 O14649 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25954205 0.93 SLC2A1 (0.59) SLC2A1ALDH1A1HPGDMEN1KMT2A
SCHEMBL1409015 0.93 SLC2A1 (0.59) SLC2A1ALDH1A1HPGDMEN1KMT2A
SCHEMBL15763654 0.86 ALDH1A1 (0.54) SLC2A1ALDH1A1RAB9AHPGDNPC1
SCHEMBL26808251 0.84 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ATSHRTDP1
SCHEMBL362964 0.82 TSHR (0.43) ALDH1A1MEN1KMT2ATSHRALOX15
SCHEMBL1793818 0.81 NR1H2 (0.48) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL6491080 0.81 SLC2A1 (0.49) SLC2A1ALDH1A1RAB9AHPGDNPC1
SCHEMBL30056216 0.79 LMNA (0.41) ALDH1A1RAB9ANPC1TSHRTDP1
SCHEMBL4796677 0.79 MEN1 (0.44) ALDH1A1MEN1KMT2ATSHRMAPK1
SCHEMBL13766167 0.79 ESR1 (0.41) SLC2A1ALDH1A1MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6444860-B1 None US disclosed
US-9487693-B2 Chromene compound TOKUYAMA CORPORATION (JP) 2016-11-08 US disclosed
US-9487693-B2 Chromene compound TOKUYAMA CORPORATION (JP) 2016-11-08 US disclosed
US-20140154527-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2014-06-05 US disclosed
US-20140154527-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2014-06-05 US disclosed
US-8709308-B2 Chromene compound TOKUYAMA CORPORATION (JP) 2014-04-29 US disclosed
US-8709308-B2 Chromene compound TOKUYAMA CORPORATION (JP) 2014-04-29 US disclosed
US-20140034884-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2014-02-06 US disclosed
US-20140034884-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2014-02-06 US disclosed
US-20140030529-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2014-01-30 US disclosed
WO-2000049010-A1 NAPHTHOPYRANS AND PHENANTHROPYRANS ANNELATED IN C5-C6 WITH A BICYCLIC GROUP, AND COMPOSITIONS AND (CO)POLYMER MATRICES CONTAINING THEM CORNING S.A. (FR) 2000-08-24 WO disclosed
EP-1000025-A1 SUBSTITUTED NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 2000-05-17 EP disclosed
EP-0628064-B1 PHOTOCHROMIC NAPHTHOPYRANS TRANSITIONS OPTICAL INC (US) 1999-04-07 EP disclosed
WO-1998055457-A1 SUBSTITUTED NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 1998-12-10 WO disclosed
US-5658500-A REVERSIBLE PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 1997-08-19 US disclosed
US-5585042-A REVERSIBLE CHANGE IN COLOR WHEN EXPOSURED TO ULTRAVIOLET RADIATION TRANSITIONS OPTICAL, INC. (US) 1996-12-17 US disclosed
EP-0628064-A1 PHOTOCHROMIC NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 1994-12-14 EP disclosed
US-5369158-A And polymer TRANSITIONS OPTICAL, INC. (US) 1994-11-29 US disclosed
WO-1993017071-A1 PHOTOCHROMIC NAPHTHOPYRANS PPG INDUSTRIES, INC. (US) 1993-09-02 WO disclosed
US-5238981-A PHOTOCHROMIC NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 1993-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140030529-A1 CHROMENE COMPOUND TST, CNOT1, CNOT9 SLC2A1 3449/4885ALDH1A1 1884/4885RAB9A 2258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.